Lung ultrasound outperforms symptom-based screening to detect interstitial lung disease associated with rheumatoid arthritis
LUS is a promising tool for early detection of RA-ILD, outperforming symptom-based questionnaires or the presence of dyspnoea or cough.
Authors
- Tinne Goos (ORCID: https://orcid.org/0000-0002-8081-333X)
- Joseph Jacob (ORCID: https://orcid.org/0000-0002-8054-2293)
- Alexandros Kalkanis (ORCID: https://orcid.org/0000-0002-1740-6782)
- Emanuela Elsa Cortesi (ORCID: https://orcid.org/0000-0003-1067-9179)
- Stefan Gogaert
- V. Taelman
- Heleen Cypers (ORCID: https://orcid.org/0000-0001-9325-5085)
- Laurens De Sadeleer (ORCID: https://orcid.org/0000-0003-1237-7369)
- Barbara Neerinckx (ORCID: https://orcid.org/0000-0001-9220-9466)
- Nico De Crem (ORCID: https://orcid.org/0000-0002-0733-0673)
- Marie Vermant (ORCID: https://orcid.org/0000-0001-8546-8638)
- Wim Wuyts (ORCID: https://orcid.org/0000-0001-9648-3497)
- Patrick Verschueren (ORCID: https://orcid.org/0000-0002-0340-3580)
- Nathalie Veyt
- Tine Follet
Institutions
- London Chest Hospital (GB)
- University College London (GB)
- KU Leuven (BE)
Publication Details
- Journal
- RMD Open
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1136/rmdopen-2024-005283
- Citations
- 9
- Primary Topic
- Ultrasound in Clinical Applications
- Type
- article
- Field-Weighted Citation Impact
- 13.91
Funders
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- F. Hoffmann-La Roche
- Wellcome Trust
- National Institute for Health and Care Research
- European Commission
- Fonds Wetenschappelijk Onderzoek
- University College London Hospitals NHS Foundation Trust
- Vlaamse regering
- UCLH Biomedical Research Centre